Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 2

touchMDT for touchNEUROLOGY

Listen to experts with multidisciplinary perspectives discuss the current treatment landscape for relapsing MS and how oral DMTs can improve patient outcomes.

The multidisciplinary team

• Neurologist/MS specialist: Prof. Mark Freedman, Canada
• Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
• Advanced practice clinician: Ms Amy Perrin Ross, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website:
https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms